Octagon Capital Advisors LP

Bedrift	Dele, %
Gossamer Bio	7.37
Reneo Pharmaceuticals, Inc.	6.73
Corbus Pharmaceuticals Holdings, Inc.	6.35
GlycoMimetics, Inc.	4.66
Unicycive Therapeutics, Inc.	4.65
Chinook Therapeutics, Inc.	3.55
Taysha Gene Therapies, Inc.	3.31
Jounce Therapeutics, Inc.	2.66
DBV Technologies S.A.	2.54
Mind Medicine (MindMed) Inc.	2.16
ChemoCentryx, Inc.	0.21
Acceleron Pharma Inc.	0.18